Osteoarthritis: priorities for osteoarthritis research: much to be done

David T Felson1

  • 1Clinical Epidemiology Research and Training Unit, Boston University School of Medicine, Suite 200, 650 Albany Street, Boston, MA 02118, USA.

Insights

European League Against Rheumatism (EULAR) guidelines aim to advance osteoarthritis treatment research. Recommendations emphasize noncartilaginous tissues, joint interactions, pain mechanisms, and early disease intervention strategies.

Area of Science:

  • Rheumatology
  • Orthopedics
  • Translational Medicine

Background:

  • Osteoarthritis (OA) treatment development has seen limited progress.
  • Existing OA research primarily focuses on cartilage degeneration.
  • A comprehensive understanding of OA pathogenesis is lacking.

Purpose of the Study:

  • To present new European League Against Rheumatism (EULAR) recommendations for osteoarthritis research.
  • To redirect OA research efforts towards more effective therapeutic strategies.
  • To address critical gaps in current OA understanding and treatment.

Main Methods:

  • Review and synthesis of existing OA research by a EULAR task force.
  • Development of consensus-based recommendations for future research directions.
  • Identification of key areas requiring focused investigation.

Main Results:

  • Recommendations prioritize noncartilaginous tissues (e.g., synovium, bone) in OA.
  • Emphasis on the complex interactions between different joint structures.
  • Highlighting the need to understand osteoarthritic pain pathogenesis.
  • Calling for novel treatment strategies and focus on early OA stages.

Conclusions:

  • EULAR recommendations provide a roadmap for advancing OA research.
  • Shifting focus beyond cartilage is crucial for developing effective OA treatments.
  • Addressing pain and early disease offers new therapeutic avenues.